News
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...
It's likely that Trump was referring to Elon Musk in the quoted tweet. Musk has publicly admitted to using weight-loss drugs ...
Vikrant Shrotriya said Human Mixtard is not being discontinued in India and will be supplied in vial presentation ...
Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...
The best metric is not weight, but a particularly toxic kind of fat.
Elon Musk is President Trump’s “seriously overweight” friend who takes “the fat shot,” according to the Tesla CEO’s own artificial intelligence bot. Trump was discussing plans to lower medication ...
European governments are examining whether U.S. President Donald Trump can force them to pay more for prescription medicines, ...
On the heels of President Donald Trump’s Monday announcement of an executive order that will slash prescription drug prices ...
22h
Pharmaceutical Technology on MSNGLP-1RAs show anti-cancer benefits beyond weight lossGlobalData analysis predicts the global GLP-1RA market will reach $168bn by 2033, with Novo Nordisk and Eli Lilly to dominate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results